acivicin has been researched along with Carcinoma, Hepatocellular in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hultberg, B; Hultberg, M | 1 |
| Weber, G | 1 |
| Kato, A; Kubo, K; Matsuzaki, Y; Okita, K; Terai, S | 1 |
| Cnaan, A; Dayal, Y; Falkson, G; Falkson, H; Haller, DG; Simson, IW; Smith, TJ | 1 |
1 review(s) available for acivicin and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.
Topics: Adenosine Monophosphate; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Deoxyribonucleotides; Gene Expression Regulation; Gluconeogenesis; Guanosine Monophosphate; Humans; Inosine Monophosphate; Isoxazoles; Kidney Neoplasms; Liver Neoplasms; Liver Regeneration; Models, Biological; Neoplasms; Purines; Pyrimidines; Ribonucleotides | 1983 |
1 trial(s) available for acivicin and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group study.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Drug Administration Schedule; Female; Humans; Isoxazoles; Liver Neoplasms; Male; Prospective Studies; Survival Rate | 1990 |
2 other study(ies) available for acivicin and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
High glutathione turnover in human cell lines revealed by acivicin inhibition of gamma-glutamyltranspeptidase and the effects of thiol-reactive metals during acivicin inhibition.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cysteine; Enzyme Inhibitors; gamma-Glutamyltransferase; Glutathione; HeLa Cells; Humans; Isoxazoles; Liver Neoplasms; Metals; Sulfhydryl Compounds | 2004 |
Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Dose-Response Relationship, Drug; Humans; In Situ Nick-End Labeling; Isoxazoles; Liver Neoplasms; Pyrazines; Quinolines; Tumor Cells, Cultured | 1999 |